Quick Takeaways
- MPM BioImpact LLC filed SCHEDULE 13G for DBV TECHNOLOGIES S.A. Ordinary Shares, nominal value 0.01 euro per share (DBVT).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2025.
MPM BioImpact LLC - 31 Dec 2025 SCHEDULE 13G Report for DBV TECHNOLOGIES S.A. Ordinary Shares, nominal value 0.01 euro per share (DBVT)
- Filing Manager
- MPM BioImpact LLC
- Reporting Manager
- MPM BioImpact LLC
- Symbol
- DBVT
- Shares outstanding
- 248,275,828 shares
- Disclosed Ownership
- 24,579,307 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 16:10:30 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MPM BioImpact LLC disclosed 9.9% ownership in DBV TECHNOLOGIES S.A. Ordinary Shares, nominal value 0.01 euro per share (DBVT) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 16:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC | 9.9% | 24,579,307 | 24,579,307 | 0 | Christopher Wolf | Chief Financial Officer |